PATENT CLAIM ANALYSIS

Application Number: 15764613
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "046000"]

Abstract:
Provided herein are compounds of Formula (I) and pharmaceuticals acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, and prodrugs thereof. Also provided are pharmaceutical compositions, kits, and methods involving the inventive compounds for the treatment of an infectious disease (e.g., bacterial infection (e.g., tuberculosis, methicillin-resistant  Staphylococcus aureus ).

Claim (Index 49):
The compound of  claim 1 , wherein X 1  is \u2014O\u2014 or \u2014NH\u2014.

Metadata:
- Claim Count in Document: 54.0
- Percentile: 90.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15904143', '16334237', '15847856', '15104132', '15847430']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.748337145113649
- 35 USC 102 Novelty (BERT): 0.5145872547519883
- Combined Prediction Score: 0.7249621560774829
- Mean Citation Score: 265.80277
- Max Citation Score: 278.9836
- Similarity Product: 211.94691731271743

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test